| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 10/14/2004 | CA2518913A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 10/13/2004 | EP1466911A2 Preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 10/13/2004 | EP1466904A1 Biaryl compound and use thereof |
| 10/13/2004 | EP1466901A1 Serotonine reuptake inhibitor |
| 10/13/2004 | EP1466624A1 Drug for regenerating tissue and vessel and method therefor |
| 10/13/2004 | EP1466621A1 Compositions for improving lipid metabolism |
| 10/13/2004 | EP1466604A1 Isoquinoline derivatives, process for their preparation and use thereof in the treatment of melatoninergic system problems |
| 10/13/2004 | EP1466602A1 Organ fibrosis inhibitors |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465890A1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
| 10/13/2004 | EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 10/13/2004 | EP1465888A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 10/13/2004 | EP1465887A1 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
| 10/13/2004 | EP1465886A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465870A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 10/13/2004 | EP1465869A1 Modulators of lxr |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465863A1 Potassium channel modulators |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465666A2 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 10/13/2004 | EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase |
| 10/13/2004 | EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/13/2004 | EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 10/13/2004 | EP1465629A1 5-ht3 receptor antagonists and methods of use |
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1465616A1 Treatment of statin side effects using uridine derivatives |
| 10/13/2004 | EP1465613A2 Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs |
| 10/13/2004 | EP1465505A2 Stimulation of the immune system with polydextrose |
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/13/2004 | EP1397106A4 Dental restorative materials |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1280820B1 Anti-inflammatory compounds and uses thereof |
| 10/13/2004 | EP1248603B1 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 10/13/2004 | EP1207866B1 Delayed-action form of administration containing tramadol saccharinate |
| 10/13/2004 | EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 10/13/2004 | EP1200151B1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 10/13/2004 | EP1187831B1 Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 10/13/2004 | EP1185529B1 Pyrazolobenzodiazepines as cdk2 inhibitors |
| 10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
| 10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 10/13/2004 | EP1154786B1 Compositions for altering mucus secretion |
| 10/13/2004 | EP1150954B1 Anti-imflammatory indole derivatives |
| 10/13/2004 | EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 10/13/2004 | EP1107746B1 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | EP0877716B1 Bioactive glass compositions for use in the treatment of tooth structures |
| 10/13/2004 | EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 10/13/2004 | EP0802912B1 Piperidine derivatives having tachykinin antagonist activity |
| 10/13/2004 | CN1537167A Von willebrand factor (VWF)-cleaving enzyme |
| 10/13/2004 | CN1537111A Urea substituted imidazoquinolines |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 10/13/2004 | CN1537017A Remedie for inflammatory bowel diseases |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 10/13/2004 | CN1536989A Oral compositions comprising host-respones modulating agent for promoting whole body health |
| 10/13/2004 | CN1536988A Sustained-release delivery system |
| 10/13/2004 | CN1536967A Nutritional composition preventing bacterial overgrowth |
| 10/13/2004 | CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative |
| 10/13/2004 | CN1535957A New isoquinoline compounds, their preparation method and medicine composition contaning them |
| 10/13/2004 | CN1535726A Molecular adjuvant, its preparation and gene vaccine containing said molecular adjuvant |
| 10/13/2004 | CN1535708A Oral aerosol for reducing or eliminating snore and its preparation method |
| 10/13/2004 | CN1535703A Health-preserving brain-supplementing medicine and its preparation method |
| 10/13/2004 | CN1535702A Antifatigue medicine and its preparation method |
| 10/13/2004 | CN1535697A Preparation of lactobacillin dispersion tablet and its preparation method |
| 10/13/2004 | CN1535688A Combined preparation containing morpholine anthracene nucleus compound and autcancer preparation |
| 10/13/2004 | CN1535622A Processing process for making beverage and food by using duck wheat as raw material |
| 10/13/2004 | CN1170933C Motilin homologs |
| 10/13/2004 | CN1170927C Method for producing medicine using silkworm expressed numan epidermal growth factor |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170829C Optically active pyrrolopyridazine compound |
| 10/13/2004 | CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 10/13/2004 | CN1170594C 弯曲菌疫苗 Campylobacter vaccine |
| 10/13/2004 | CN1170590C Health-care product containing growth factor and its preparation method |
| 10/13/2004 | CN1170587C I (Robinia Pseudoacacia) lectin and its uses |
| 10/13/2004 | CN1170582C Medicine composition for treating mouth and gingiva, gullet diseases |
| 10/13/2004 | CN1170581C Medicine composition for treating dysentery and enteritis |
| 10/13/2004 | CN1170572C Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof |
| 10/13/2004 | CN1170568C Capsule for treating stomach disease and its preparing method |
| 10/13/2004 | CN1170560C Health care medical tea and production method thereof |
| 10/13/2004 | CN1170559C Capsule for removing heat from liver and dewtoxicating and its preparing process |
| 10/13/2004 | CN1170555C Chinese patent medicine for treating ulcer diseases |
| 10/13/2004 | CN1170543C Use of PEG-IFN-alpha and triazloe nucleoside for treatment of chronic hepatitis C |
| 10/13/2004 | CN1170536C Use of preparing medicine for preventing vomit using tetrahydrobenzo [cd] indole-6-formylamine compound |
| 10/13/2004 | CN1170535C Use of medicine for treatment of migraikne by the administration of alpha-lipoic acid |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803362 Heterocyclic compounds |
| 10/07/2004 | WO2004085471A2 Glp-2 derivatives |
| 10/07/2004 | WO2004085424A1 Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
| 10/07/2004 | WO2004085422A1 Water-soluble thalidomine derivatives |
| 10/07/2004 | WO2004084945A1 Eating controllers |